Warfarin has (mostly) been replaced by newer thinners like Dabigatran, Rivaroxaban, and Apixaban, which are much less dose dependent. Generally thinners are onl

Warfarin has (mostly) been replaced by newer thinners like Dabigatran, Rivaroxaban, and Apixaban, which are much less dose dependent. Generally thinners are only given to people who have a moderate/severe risk of stroke or heart disease. All the thinners don't just depend on dose but also on (e.g.) the amount of Vitamin K from leafy greens. If we survive the next century (looking unlikely...) it's a fair bet that mixing AI analysis with live biochemical tracking and as-required synthesis would be the next Big Thing. Current medications are extremely crude and have hit-and-miss outcomes because the combination of diet, genetics, gender, activity levels, age, and stress (etc) all have huge effects on individual biochemistry.